Physician profile
Freddie L Everson
NPI 1497728638
$2,769.27
in general payments reported to CMS, 2019-2025
19 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,189 · 2020: $194 · 2021: $228 · 2022: $168 · 2023: $178 · 2024: $526 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $990.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $989.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $785.02 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $578.08 | 2019-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $290.07 | 2019-2025 | Synjardy, Jardiance |
| Sanofi-Aventis U.S. LLC | $263.73 | 2019-2023 | |
| Lilly USA, LLC | $184.65 | 2022-2025 | Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $115.31 | 2019-2022 | |
| Pfizer INC. | $98.68 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $94.16 | 2019-2025 | Capvaxive, Gardasil 9 |
| Glaxosmithkline, LLC. | $75.07 | 2019-2023 | Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $62.22 | 2022-2023 | |
| Abbott Laboratories | $44.57 | 2021 | |
| Daiichi Sankyo INC. | $33.66 | 2025 | Injectafer |
| Exact Sciences Corporation | $29.96 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Abbvie INC. | $28.23 | 2019-2022 | |
| Amgen INC. | $21.44 | 2024 | Otezla, Repatha |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $17.61 | 2019 | |
| Mannkind Corporation | $16.79 | 2019 | |
| Allergan, INC. | $15.47 | 2019 | |
| Sunovion Pharmaceuticals INC. | $14.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Freddie Everson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.